Skip navigation
A Novel Molecule Targets Leukemia and Lymphoma Cells

Narrator: This is Science Today. Researchers at the University of California, Davis Cancer Center have developed a novel molecule that targets leukemia and lymphoma cells. Dr. Kit Lam, chief of Hematology Oncology at the cancer center, says this peptide demonstrates great promise as an imaging and therapeutic agent.

Lam: So, if the molecule identified can carry the imaging agent right at the tumor site, the same thing will also be true that we can carry the therapeutic agent to the tumor sites and therefore cure the cancer specifically, just like what we call a "magic bullet" that goes to the cancer and kills it. That's what we like to do.

Narrator: The next step is to evaluate the binding of this peptide in a larger number of human lymphoma biopsy samples. In the future, Lam says this molecule may target other cancers, too.

Lam: Now we have molecules that bind to ovarian cancer, brain cancer, lung cancer and pancreatic cancer. So, those are something we actually are working on as well, not just lymphoma. Hopefully, we'll find a ‘magic bullet' for each of those cancer types.

Narrator: For Science Today, I'm Larissa Branin.